Works matching IS 10837159 AND DT 2024 AND VI 29 AND IP 7
Results: 24
The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
- By:
- Publication type:
- Article
Unleashing patient voices: empowering adverse event assessment with complete patient-reported outcomes.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e953, doi. 10.1093/oncolo/oyae105
- By:
- Publication type:
- Article
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 575, doi. 10.1093/oncolo/oyae099
- By:
- Publication type:
- Article
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 638, doi. 10.1093/oncolo/oyae096
- By:
- Publication type:
- Article
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e910, doi. 10.1093/oncolo/oyae093
- By:
- Publication type:
- Article
Cognitive impairment following breast cancer treatments: an umbrella review.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e848, doi. 10.1093/oncolo/oyae090
- By:
- Publication type:
- Article
Oncology drug pricing: potential Medicare savings on cancer-directed and supportive care medications through the Mark Cuban cost plus drug model.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e918, doi. 10.1093/oncolo/oyae083
- By:
- Publication type:
- Article
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 560, doi. 10.1093/oncolo/oyae082
- By:
- Publication type:
- Article
High-value breast cancer care within resource limitations.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e899, doi. 10.1093/oncolo/oyae080
- By:
- Publication type:
- Article
Perception of Polish patients with cancer of the ethical and legal issues related to biobank research.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e887, doi. 10.1093/oncolo/oyae078
- By:
- Publication type:
- Article
The value of virtual molecular tumor boards for informed clinical decision-making.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 554, doi. 10.1093/oncolo/oyae077
- By:
- Publication type:
- Article
Harvesting information from Kaplan-Meier plots: part 1—detecting censoring.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 551, doi. 10.1093/oncolo/oyae070
- By:
- Publication type:
- Article
The cancer caregiving burden trajectory over time: varying experiences of perceived versus objectively measured burden.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 629, doi. 10.1093/oncolo/oyae069
- By:
- Publication type:
- Article
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 547, doi. 10.1093/oncolo/oyae067
- By:
- Publication type:
- Article
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 566, doi. 10.1093/oncolo/oyae064
- By:
- Publication type:
- Article
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 619, doi. 10.1093/oncolo/oyae054
- By:
- Publication type:
- Article
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 589, doi. 10.1093/oncolo/oyae037
- By:
- Publication type:
- Article
Storage, Disposal, and Use of Opioids Among Cancer Patients in Central China: A Multi-Center Cross-Sectional Study.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e941, doi. 10.1093/oncolo/oyae049
- By:
- Publication type:
- Article
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e922, doi. 10.1093/oncolo/oyae048
- By:
- Publication type:
- Article
Comparison of the Response to Neoadjuvant Therapy Between Immunohistochemistry HER2 (3+) and HER2 (2+)/ISH+ Early-Stage Breast Cancer: A Retrospective Multicenter Cohort Study.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e877, doi. 10.1093/oncolo/oyae047
- By:
- Publication type:
- Article
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 596, doi. 10.1093/oncolo/oyae043
- By:
- Publication type:
- Article
Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e932, doi. 10.1093/oncolo/oyae052
- By:
- Publication type:
- Article
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 581, doi. 10.1093/oncolo/oyae019
- By:
- Publication type:
- Article
Association between Homologous Recombination Repair Defect Status and Long-Term Prognosis of Early HER2-Low Breast Cancer: A Retrospective Cohort Study.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e864, doi. 10.1093/oncolo/oyae021
- By:
- Publication type:
- Article